Blog: MS news

NICE rejects Sativex in draft guidance on cannabis-based medicinal products

15 August 2019

Source MS Trust: Draft guidance published today on August 8 does not recommend Sativex as a treatment for MS spasticity because it is not a cost-effective treatment.

The MS Trust have launched a new pack to help teachers and pupils raise awareness of MS and dispel some common myths and misunderstandings

15 August 2019

Source MS Trust: MS Trust supporter Jenna Chudasama teaches at a secondary school in Leicester and recently used the pack to deliver an assembly to students about her own MS experience. “I hope that I inspired others to live their life to the full, no matter what challenges they are faced with,” Jenna tells us.

Grant from MS Society, Parkinson’s UK to Establish Digital Brain Bank

15 August 2019

Source Parkinson's News Today: The Multiple Sclerosis (MS) and Parkinson’s Tissue Bank at Imperial College London, is the largest repository of brain and spinal cord tissue samples in Europe.

EMA warns that Gilenya must not be taken during pregnancy.

30 July 2019

Source MS Trust: The European Medicines Agency (EMA) has recommended that Gilenya (fingolimod) must not be taken by pregnant women or women of childbearing age who are not using effective contraception.

Independent Mouse Study Reinforces Remyelinating Potential of ISP Therapy

23 July 2019

Source Multiple Sclerosis News Today: A new study demonstrates that intracellular sigma peptide (ISP) can promote remyelination in a mouse model of multiple sclerosis (MS).

The MS Society is hosting a talk on stem cell treatments for people MS in Cheltenham on the 28th of September.

23 July 2019

Source MS Society: Join us for an afternoon with Dr Claire Rice, Neurologist and MS Researcher in Bristol. Claire will give an overview about stem cell treatment for MS including its current role in disease management and research priorities.

Daily living made easy public event - Windsor and Maidenhead

23 July 2019

Windsor & Maidenhead: There’s no better place to discover what’s available to support independent living than by attending a public event designed specifically with that in mind.

3-D Brain Models of PPMS and Parkinson’s Off to Space Station for Research in Microgravity

23 July 2019

Source Multiple Sclerosis News Today: The National Stem Cell Foundation (NSCF) announced the start of a pioneering project to investigate the impact of microgravity on the neurodegeneration associated with primary progressive multiple sclerosis (PPMS) and Parkinson’s disease.